Goldman Sachs Cuts BJ's (BJ) to Neutral; Removes from Conviction Buy List
Tweet Send to a FriendGet Alerts BJ Hot Sheet
Price: $51.24 --0%
Rating Summary:
0 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 6
Rating Summary:
0 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 0 | Down: 1 | New: 6
Trade BJ Now!
Goldman Sachs downgraded shares of BJ's Wholesale (NYSE: BJ) from Buy to Neutral and also removed the stock from its "Conviction Buy List."
Wednesday's lowered investment rating follows a private-equity agreement to acquire the company for $2.8 billion.
Notably, the firm lowered its price target on the shares of BJ's from $60 to $53.
For more ratings news on BJs Wholesale click here and for the rating history of BJs Wholesale click here.
Shares of BJs Wholesale closed at $48.08 yesterday, with a 52 week range of $36.77-$52.46.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Wednesday's lowered investment rating follows a private-equity agreement to acquire the company for $2.8 billion.
Notably, the firm lowered its price target on the shares of BJ's from $60 to $53.
For more ratings news on BJs Wholesale click here and for the rating history of BJs Wholesale click here.
Shares of BJs Wholesale closed at $48.08 yesterday, with a 52 week range of $36.77-$52.46.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: UBS Downgrades Carnival (CCL) to Neutral; Worst May Not Be Behind
- UPDATE: Wedbush Downgrades XenoPort (XNPT) to Neutral
- Goldman Sachs Upgrades Abbott Labs (ABT) to Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
Goldman Sachs Conviction Buy List, Goldman SachsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

